Plus   Neg

Mylan Holding On To Substantial Gain In Afternoon Trading

Share of Mylan (MYL) continue to see considerable strength in afternoon trading on Wednesday after an early rally. After reaching a two-month intraday high, Mylan is currently up by 18.3 percent.

The jump by Mylan comes after the FDA approved two doses of the drug maker's generic version of Teva's (TEVA) Copaxone for patients with relapsing forms of multiple sclerosis.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Business software giant Oracle Corp. (ORCL), Monday said it swung to a third-quarter loss after taking a $6.9 billion charge related to the new U.S. tax law. Revenues for the quarter grew 6 percent reflecting strong growth in cloud revenues. Adjusted earnings for the quarter trumped Wall Street estimates,... Canada-based cannabis company Cronos Group Inc. (CRON) and MM Enterprises USA LLC said Monday that they have formed a cross-border joint venture to cater to Canadian consumers. The move comes as Canada plans to legalize adult use of cannabis by the end of this year. MM Enterprises USA, LLC is a U.S. cannabis company with facilities in California, Nevada, and New York. Qualcomm Inc.'s former Chairman Paul Jacobs plans to acquire the chipmaker founded by his father and has approached several global investors in an effort to fund the buyout, the Financial Times reported. According to the report, Jacobs informed members of the Qualcomm board about his intention to take the company private. Qualcomm has a market capitalization of $90 billion.
comments powered by Disqus
Follow RTT